|
|
|
|
|
|
||
|
|
||||
|
|
||||
|
||||
Neuropathology |
Departments of Neurosurgery (I.E.M., S.J.H.), Pathology (G.N.F.), and Endocrinology (W.J., G.J.C), The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
1 Address correspondence to Ian E. McCutcheon, Department of Neurosurgery, M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 442, Houston, TX 77030-4009 (imccutch{at}mdanderson.org).
Abstract
Polypyrimidine tract-binding protein (PTB) is a nuclear factor that binds to the polypyrimidine tract of premRNA introns, where it is associated with negative regulation of RNA splicing and with exon silencing. We have previously demonstrated that PTB expression is increased during glial cell transformation and that this increase correlates with changes in the RNA splicing of the fibroblast growth factor receptor 1. In this paper we examine the specific cellular distribution of PTB expression in normal brain and in glial and neuronal tumors. Paraffin sections were stained by using a primary monoclonal antibody against PTB. Tissues that were analyzed included normal brain (n = 2) and tumors of various types (low-grade astrocytoma, n = 2; anaplastic astrocytoma, n = 2; glioblastoma, n = 4; medulloblastoma, n = 4; central neurocytoma, n = 2; dysplastic gangliocytoma, n = 1; ganglioglioma, n = 1; paraganglioma, n = 1). In glial cell populations the majority of astrocytes and oligodendrocytes were negative, but occasional positively staining cells were observed. Strongly positive PTB staining was observed in ependymocytes, choroid plexus epithelium, microglia, arachnoid membrane, and adenohypophysis, and weak staining was found in the neurohypophysis. In all cases vascular endothelium and smooth muscle stained strongly. In tumor samples, intense positive nuclear staining was observed in transformed cells of low-grade astrocytoma, anaplastic astrocytoma, glioblastoma multiforme, medulloblastoma, paraganglioma, and the glial population of both ganglioglioma and dysplastic gangliocytoma (the neuronal cells of both were negative). In medulloblastoma, neoplastic neuronal cells were positive, as were other cell lineages. In normal brain, all neuron populations and pineocytes were negative for PTB. We conclude that although glial cells show derepression of PTB expression, a similar mechanism is absent in both nonneoplastic neurons and in most neuronally derived tumor cells. Strong upregulation of PTB expression in tumor cells of glial or primitive neuroectodermal origin suggests involvement of this protein in cellular transformation. Whether PTB affects splicing of RNAs critical to cellular transformation or proliferation is an important question for future research.
References
Cartegni, L., Chew, S.L., and Krainer, A.R. (2002) Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285-298.[CrossRef][ISI][Medline]
Cote, J., Dupuis, S., and Wu, J.Y. (2001)
Polypyrimidine track-binding protein binding downstream of the caspase-2
alternative exon 9 represses its inclusion. J. Biol.
Chem. 276,8535
-8543.
Faustino, N.A., and Cooper, T.A. (2003) Pre-mRNA
splicing and human dis ease. Genes Dev.
17,419
-437.
Galzie, Z., Kinsella, A.R., and Smith, J.A. (1997) Fibroblast growth factors and their receptors. Biochem. Cell Biol. 75,669 -685.[CrossRef][ISI][Medline]
Garcia-Blanco, M.A., Jamison, S.F., and Sharp, P.A.
(1989) Identification and purification of a 62,000-dalton protein
that binds specifically to the polypyrimidine tract of introns.
Genes Dev. 3,1874
-1886.
Grossman, J.S., Meyer, M.I., Wang, Y.C., Mulligan, G.J., Kobayashi, R., and Helfman, D.M. (1998) The use of antibodies to the polypyrimidine tract binding protein (PTB) to analyze the protein components that assemble on alternatively spliced pre-mRNAs that use distant branch points. RNA 4,613 -625.[Abstract]
Jin, W., Bi, W., Huang, E.S., and Cote, G.J. (1999a)
Glioblastoma cell-specific expression of fibroblast growth factor receptor-1b
requires an intronic repressor of RNA splicing. Cancer
Res. 59,316
-319.
Jin, W., Huang, E.S., Bi, W., and Cote G.J. (1999b)
Redundant intronic repressors function to inhibit fibroblast growth factor
receptor-1 
-exon recog nition in glioblastoma cells. J.
Biol. Chem. 274,28035
-28041.
Jin, W., McCutcheon, I.E., Fuller, G.N., Huang, E.S., and Cote,
G.J. (2000) Fibroblast growth factor receptor-1 -exon
exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme
tumors. Cancer Res. 60,1221
-1224.
Johnson, D.E., and Williams, L.T. (1993) Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res. 60,1 -41.[ISI][Medline]
Katsetos, C.D., and Burger, P.C. (1994) Medulloblastoma. Semin. Diagn. Pathol. 11, 85-97.[ISI][Medline]
Maher, E.A., Furnari, F.B., Bachoo, R.M., Rowitch, D.H., Louis,
D.N., Cavenee, W.K., and DePinho, R.A. (2001) Malignant glioma:
Genetics and biology of a grave matter. Genes Dev.
15,1311
-1333.
Maniatis, T., and Tasic, B. (2002) Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418,236 -243.[CrossRef][Medline]
Moore, K., and Persaud, T. (1998) The nervous system, in The Developing Human: Clinically Oriented Embryology, 6th ed. Philadelphia: W.B. Saun ders Company, pp.451 -489.
Nissim-Rafinia, M., and Keren, B. (2002) Splicing regulation as a potential genetic modifier. Trends Genet. 18,123 -127.[CrossRef][ISI][Medline]
Sehgal, A. (1998) Molecular changes during the genesis of human gliomas. Semin. Surg. Oncol. 14, 3-12.[CrossRef][ISI][Medline]
Trojanowski, J.Q., Tohyama, T., and Lee, V.M. (1992) Medulloblastomas and related primitive neuroectodermal brain tumors of childhood recapitu late molecular milestones in the maturation of neuroblasts. Mol. Chem. Neuropathol. 17,121 -135.[ISI][Medline]
Valcarcel, J., and Gebauer, F. (1997) Post-transcriptional regulation: The dawn of PTB. Curr. Biol. 7,R705 -R708.[CrossRef][ISI][Medline]
VandenBerg, S.R., Herman, M.M., and Rubinstein, L.J. (1987) Embryonal central neuroepithelial tumors: Current concepts and future challenges. Cancer Metastasis Rev. 5, 343-365.[CrossRef][ISI][Medline]
Wagner, E.J., and Garcia-Blanco, M.A. (2001)
Polypyrimidine tract binding protein antagonizes exon definition.
Mol. Cell. Biol. 21,3281
-3288.
Wang, J., and Pederson, T. (1990) A 62,000 molecular
weight spliceosome protein crosslinks to the intron polypyrimidine tract.
Nucleic Acids Res. 18,599
-6001.
Yamaguchi, F., Saya, H., Bruner, J.M., and Morrison R.S.
(1994) Differential expression of two fibroblast growth
factor-receptor genes is associated with malignant progression in human
astrocytomas. Proc. Natl. Acad. Sci. USA
91,484
-488.
This article has been cited by other articles:
|
|
 |
|
  C. Wang, J. T. Norton, S. Ghosh, J. Kim, K. Fushimi, J. Y. Wu, M. S. Stack, and S. Huang Polypyrimidine Tract-binding Protein (PTB) Differentially Affects Malignancy in a Cell Line-dependent Manner J. Biol. Chem., July 18, 2008; 283(29): 20277 - 20287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Somberg, X. Zhao, M. Frohlich, M. Evander, and S. Schwartz Polypyrimidine Tract Binding Protein Induces Human Papillomavirus Type 16 Late Gene Expression by Interfering with Splicing Inhibitory Elements at the Major Late 5' Splice Site, SD3632 J. Virol., April 1, 2008; 82(7): 3665 - 3678. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. I. Bonano, S. Oltean, R. M. Brazas, and M. A. Garcia-Blanco Imaging the alternative silencing of FGFR2 exon IIIb in vivo RNA, December 1, 2006; 12(12): 2073 - 2079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. SHUKLA, F. DEL GATTO-KONCZAK, R. BREATHNACH, and S. A. FISHER Competition of PTB with TIA proteins for binding to a U-rich cis-element determines tissue-specific splicing of the myosin phosphatase targeting subunit 1 RNA, November 1, 2005; 11(11): 1725 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Perreault, J.-F. Noel, F. Briere, B. Cousineau, J.-F. Lucier, J.-P. Perreault, and G. Boire Retropseudogenes derived from the human Ro/SS-A autoantigen-associated hY RNAs Nucleic Acids Res., April 7, 2005; 33(6): 2032 - 2041. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Venables Aberrant and Alternative Splicing in Cancer Cancer Res., November 1, 2004; 64(21): 7647 - 7654. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
